D |
2025-03-24 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--D |
5445.0000 |
0.0000 |
6 |
0001178670 |
Stock Option (right to buy) |
D |
2025-03-24 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
5445.0000 |
20221.0000 |
3 |
0001178670 |
Common Stock |
A |
2025-03-24 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--D |
5445.0000 |
25666.0000 |
2 |
0001178670 |
Common Stock |
D |
2025-03-21 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
4321.0000 |
20221.0000 |
1 |
0001178670 |
Common Stock |
D |
2025-03-04 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
120.0000 |
24542.0000 |
15 |
0001178670 |
Common Stock |
D |
2025-03-04 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
198.0000 |
24662.0000 |
14 |
0001178670 |
Common Stock |
D |
2025-03-04 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
343.0000 |
24860.0000 |
13 |
0001178670 |
Common Stock |
D |
2025-03-04 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
147.0000 |
25203.0000 |
12 |
0001178670 |
Common Stock |
A |
2025-03-03 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
7819.0000 |
7819.0000 |
18 |
0001178670 |
Stock Option (right to buy) |
D |
2025-03-03 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
117.0000 |
25350.0000 |
11 |
0001178670 |
Common Stock |
D |
2025-03-03 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
273.0000 |
25467.0000 |
10 |
0001178670 |
Common Stock |
D |
2025-03-03 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
583.0000 |
25740.0000 |
9 |
0001178670 |
Common Stock |
D |
2025-03-03 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
1.0000 |
26323.0000 |
8 |
0001178670 |
Common Stock |
D |
2025-03-03 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
5.0000 |
26324.0000 |
7 |
0001178670 |
Common Stock |
D |
2025-03-03 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
48.0000 |
26329.0000 |
6 |
0001178670 |
Common Stock |
D |
2025-03-03 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
116.0000 |
26377.0000 |
5 |
0001178670 |
Common Stock |
D |
2025-03-03 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
158.0000 |
26493.0000 |
4 |
0001178670 |
Common Stock |
D |
2025-03-03 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
235.0000 |
26651.0000 |
3 |
0001178670 |
Common Stock |
D |
2025-03-03 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
213.0000 |
26886.0000 |
2 |
0001178670 |
Common Stock |
A |
2025-03-03 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
14137.0000 |
27099.0000 |
1 |
0001178670 |
Common Stock |
D |
2025-02-28 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
69.0000 |
12962.0000 |
9 |
0001178670 |
Common Stock |
D |
2025-02-28 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
142.0000 |
13031.0000 |
8 |
0001178670 |
Common Stock |
D |
2025-02-28 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
352.0000 |
13173.0000 |
7 |
0001178670 |
Common Stock |
D |
2025-02-28 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
149.0000 |
13525.0000 |
6 |
0001178670 |
Common Stock |
D |
2025-02-28 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
91.0000 |
13674.0000 |
5 |
0001178670 |
Common Stock |
D |
2025-02-28 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
41.0000 |
13765.0000 |
4 |
0001178670 |
Common Stock |
D |
2025-02-28 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
40.0000 |
13806.0000 |
3 |
0001178670 |
Common Stock |
D |
2025-02-28 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
51.0000 |
13846.0000 |
2 |
0001178670 |
Common Stock |
D |
2025-02-27 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--D |
1908.0000 |
1908.0000 |
12 |
0001178670 |
Restricted Stock Units |
A |
2025-02-27 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--D |
1908.0000 |
13897.0000 |
1 |
0001178670 |
Common Stock |
D |
2025-02-18 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
80.0000 |
11989.0000 |
19 |
0001178670 |
Common Stock |
D |
2025-02-18 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
107.0000 |
12069.0000 |
18 |
0001178670 |
Common Stock |
D |
2025-02-18 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
83.0000 |
12176.0000 |
17 |
0001178670 |
Common Stock |
D |
2025-02-18 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
110.0000 |
12259.0000 |
16 |
0001178670 |
Common Stock |
D |
2025-02-18 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
306.0000 |
12369.0000 |
15 |
0001178670 |
Common Stock |
D |
2025-02-18 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
862.0000 |
12675.0000 |
14 |
0001178670 |
Common Stock |
D |
2025-02-14 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
49.0000 |
13656.0000 |
10 |
0001178670 |
Common Stock |
D |
2025-02-14 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
349.0000 |
14749.0000 |
2 |
0001178670 |
Common Stock |
D |
2025-02-14 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
386.0000 |
14363.0000 |
3 |
0001178670 |
Common Stock |
D |
2025-02-14 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
258.0000 |
14105.0000 |
4 |
0001178670 |
Common Stock |
D |
2025-02-14 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
110.0000 |
13995.0000 |
5 |
0001178670 |
Common Stock |
D |
2025-02-14 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
126.0000 |
13869.0000 |
6 |
0001178670 |
Common Stock |
D |
2025-02-14 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
60.0000 |
13809.0000 |
7 |
0001178670 |
Common Stock |
D |
2025-02-14 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
27.0000 |
13705.0000 |
9 |
0001178670 |
Common Stock |
D |
2025-02-14 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
77.0000 |
13732.0000 |
8 |
0001178670 |
Common Stock |
D |
2025-02-14 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
60.0000 |
13596.0000 |
11 |
0001178670 |
Common Stock |
D |
2025-02-14 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
27.0000 |
13569.0000 |
12 |
0001178670 |
Common Stock |
D |
2025-02-14 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
32.0000 |
13537.0000 |
13 |
0001178670 |
Common Stock |
A |
2025-02-13 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
3109.0000 |
15098.0000 |
1 |
0001178670 |
Common Stock |
D |
2025-01-27 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--D |
23876.0000 |
0.0000 |
7 |
0001178670 |
Stock Option (right to buy) |
D |
2025-01-27 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--D |
25000.0000 |
0.0000 |
6 |
0001178670 |
Performance Stock Option 2015 (right to buy) |
D |
2025-01-27 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
52592.0000 |
11989.0000 |
3 |
0001178670 |
Common Stock |
A |
2025-01-27 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--D |
25000.0000 |
64581.0000 |
2 |
0001178670 |
Common Stock |
A |
2025-01-27 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--D |
23876.0000 |
39581.0000 |
1 |
0001178670 |
Common Stock |
D |
2024-12-12 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
121.0000 |
17336.0000 |
1 |
0001178670 |
Common Stock |
D |
2024-12-12 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
186.0000 |
17150.0000 |
2 |
0001178670 |
Common Stock |
D |
2024-12-12 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
426.0000 |
16724.0000 |
3 |
0001178670 |
Common Stock |
D |
2024-12-12 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
778.0000 |
15946.0000 |
4 |
0001178670 |
Common Stock |
D |
2024-12-12 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
140.0000 |
15706.0000 |
6 |
0001178670 |
Common Stock |
D |
2024-12-12 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
1.0000 |
15705.0000 |
7 |
0001178670 |
Common Stock |
D |
2024-12-12 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
100.0000 |
15846.0000 |
5 |
0001178670 |
Common Stock |
D |
2024-11-26 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
97.0000 |
17457.0000 |
6 |
0001178670 |
Common Stock |
D |
2024-11-26 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
945.0000 |
17554.0000 |
5 |
0001178670 |
Common Stock |
D |
2024-11-26 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
364.0000 |
18499.0000 |
4 |
0001178670 |
Common Stock |
D |
2024-11-26 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
246.0000 |
18863.0000 |
3 |
0001178670 |
Common Stock |
D |
2024-11-26 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
30.0000 |
19109.0000 |
2 |
0001178670 |
Common Stock |
A |
2024-11-25 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
3434.0000 |
19139.0000 |
1 |
0001178670 |
Common Stock |
A |
2024-10-08 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
96.0000 |
15705.0000 |
1 |
0001178670 |
Common Stock |
D |
2024-06-25 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
78.0000 |
17634.0000 |
2 |
0001178670 |
Common Stock |
D |
2024-06-25 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
17.0000 |
17617.0000 |
3 |
0001178670 |
Common Stock |
D |
2024-06-25 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
24.0000 |
17593.0000 |
4 |
0001178670 |
Common Stock |
D |
2024-06-25 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
45.0000 |
17548.0000 |
5 |
0001178670 |
Common Stock |
D |
2024-06-25 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
169.0000 |
17379.0000 |
6 |
0001178670 |
Common Stock |
D |
2024-06-25 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
348.0000 |
17031.0000 |
7 |
0001178670 |
Common Stock |
D |
2024-06-25 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
242.0000 |
15828.0000 |
12 |
0001178670 |
Common Stock |
D |
2024-06-25 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
398.0000 |
16633.0000 |
8 |
0001178670 |
Common Stock |
D |
2024-06-25 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
219.0000 |
15609.0000 |
13 |
0001178670 |
Common Stock |
D |
2024-06-25 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
129.0000 |
16504.0000 |
9 |
0001178670 |
Common Stock |
D |
2024-06-25 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
151.0000 |
16070.0000 |
11 |
0001178670 |
Common Stock |
D |
2024-06-25 |
|
ALNYLAM PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
283.0000 |
16221.0000 |
10 |
0001178670 |
Common Stock |